Showing 59,861 - 59,880 results of 121,825 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((non decrease) OR (point decrease)) ))', query time: 1.36s Refine Results
  1. 59861

    Inducible Bronchus-Associated Lymphoid Tissue Elicited by a Protein Cage Nanoparticle Enhances Protection in Mice against Diverse Respiratory Viruses by James A. Wiley (250433)

    Published 2009
    “…</p><h3>Conclusions/Significance</h3><p>The immunoprophylactic strategy described utilizes an infection-independent induction of naturally occurring iBALT prior to infection by a pulmonary viral pathogen. This strategy non-specifically enhances primary immunity to respiratory viruses and is not restricted by the antigen specificities inherent in typical vaccination strategies. …”
  2. 59862

    Table_1_IL-1β Blockade Attenuates Thrombosis in a Neutrophil Extracellular Trap-Dependent Breast Cancer Model.docx by Tainá Gomes (628536)

    Published 2019
    “…On the other hand, mice bearing non-metastatic 67NR tumors showed no elevation in neutrophil counts and displayed low expression levels of G-CSF and IL-1β in their tumors. 4T1 tumor-bearing mice but not 67NR tumor-bearing mice exhibited a NET-dependent prothrombotic state. …”
  3. 59863

    Detection of Venom after Antivenom Is Not Associated with Persistent Coagulopathy in a Prospective Cohort of Russell's Viper (<i>Daboia russelii</i>) Envenomings by Kalana Maduwage (527730)

    Published 2014
    “…Fibrinogen concentrations increased and INR decreased after antivenom in both the recurrence and non-recurrence patients. …”
  4. 59864
  5. 59865

    Characterization of a Novel Small Molecule Subtype Specific Estrogen-Related Receptor α Antagonist in MCF-7 Breast Cancer Cells by Michael J. Chisamore (263944)

    Published 2009
    “…Research suggests that ERRα may be a novel drug target to treat breast cancer and/or metabolic disorders and this has led to an effort to characterize the mechanisms of action of N-[(2Z)-3-(4,5-dihydro-1,3-thiazol-2-yl)-1,3-thiazolidin-2-yl idene]-5H dibenzo[a,d]<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0005624#pone.0005624-Vanacker1">[7]</a>annulen-5-amine, a novel ERRα specific antagonist.…”
  6. 59866
  7. 59867

    The flow diagram of the eligible studies. by Hao Han (412732)

    Published 2024
    “…<div><p>Background</p><p>The long non-coding RNA cancer susceptibility candidate (CASC) has abnormal expression in lung cancer tissues and may correlate with lung cancer prognosis. …”
  8. 59868

    Model vs. WKY group KEGG pathways (Top 15). by Xiao Zhang (152326)

    Published 2025
    “…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …”
  9. 59869

    Behavioral data. by Xiao Zhang (152326)

    Published 2025
    “…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …”
  10. 59870

    OPLS-DA model parameter. by Xiao Zhang (152326)

    Published 2025
    “…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …”
  11. 59871

    Model vs. SHR group KEGG pathways (Top 15). by Xiao Zhang (152326)

    Published 2025
    “…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …”
  12. 59872

    DataSheet_1_Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in China.docx by Jiaxin Liu (833821)

    Published 2023
    “…A total of 133 patients developed progression within 24 months from the initiation of first line anti-CD20 chemotherapy (POD24), and these patients exhibited poorer response rates and outcomes in subsequent lines of therapycompared to the non-POD24 group.…”
  13. 59873

    Diagnostic criteria for Alcoholic cardiomyopathy. by Fei Yan (128878)

    Published 2025
    “…</p><p><b>Results:</b> Globally, ACM burden showed significant declines from 1990 to 2021, with age-standardized rates decreasing by 22.5-37.1% across prevalence, mortality and disability measures. …”
  14. 59874

    Data_Sheet_2_Time-Dependent Effect of Anthracycline-Based Chemotherapy on Central Arterial Stiffness: A Systematic Review and Meta-Analysis.DOCX by Caroline Schneider (12997389)

    Published 2022
    “…Short-term (2–4 months), there was a clinically meaningful increase in arterial stiffness, namely an increase in PWV of 2.05 m/s (95% CI 0.68–3.43) and a decrease in AD (albeit non-significant) of −1.49 mmHg-1 (−3.25 to 0.27) but a smaller effect was observed mid-term (6–12 months) for PWV of 0.88 m/s (−0.25 to 2.02) and AD of −0.37 mmHg-1 (−1.13 to 0.39). …”
  15. 59875

    DataSheet_1_Association of Preadmission Metformin Use and Prognosis in Patients With Sepsis and Diabetes Mellitus: A Systematic Review and Meta-Analysis.zip by Yuanzhe Li (6529)

    Published 2021
    “…Background and Aim<p>A growing body of evidence suggests that preadmission metformin use could decrease the mortality of septic patients with diabetes mellitus (DM); however, the findings remain controversial. …”
  16. 59876

    Data_Sheet_1_Time-Dependent Effect of Anthracycline-Based Chemotherapy on Central Arterial Stiffness: A Systematic Review and Meta-Analysis.DOCX by Caroline Schneider (12997389)

    Published 2022
    “…Short-term (2–4 months), there was a clinically meaningful increase in arterial stiffness, namely an increase in PWV of 2.05 m/s (95% CI 0.68–3.43) and a decrease in AD (albeit non-significant) of −1.49 mmHg-1 (−3.25 to 0.27) but a smaller effect was observed mid-term (6–12 months) for PWV of 0.88 m/s (−0.25 to 2.02) and AD of −0.37 mmHg-1 (−1.13 to 0.39). …”
  17. 59877

    Table_1_Effectiveness of the use of an oscillating positive expiratory pressure device in bronchiectasis with frequent exacerbations: a single-arm pilot study.docx by So Rae Kim (15456707)

    Published 2023
    “…Of all enrolled patients, only two acute exacerbations occurred during the study period, indicating a significant decrease compared with the number of acute exacerbations before the device use (p < 0.001). …”
  18. 59878

    Data_Sheet_1_Healthcare Capacity, Health Expenditure, and Civil Society as Predictors of COVID-19 Case Fatalities: A Global Analysis.docx by Jahidur Rahman Khan (4268650)

    Published 2020
    “…This global study evaluates the association between multi-factorial healthcare capacity and case fatality of COVID-19 patients by adjusting for demographic, health expenditure, population density, and prior burden of non-communicable disease. It also explores the impact of government relationships with civil society as a predictor of infection and mortality rates.…”
  19. 59879

    Parameter of qualitative analysis. by Marta Ramos-Barbero (22553199)

    Published 2025
    “…In cases where EPI is contraindicated, nutritional supplementation may serve as a viable non-invasive alternative, promoting faster healing and improved long-term outcomes. …”
  20. 59880

    Image_1_Dystrophin Is Required for the Proper Timing in Retinal Histogenesis: A Thorough Investigation on the mdx Mouse Model of Duchenne Muscular Dystrophy.JPEG by Irene Persiconi (453754)

    Published 2020
    “…Immunolabeling for specific cell markers also evidenced a significant dysregulation in the number of GABAergic amacrine cells (P5–P10), a transient decrease in the area immunopositive for the Vesicular Glutamate Transporter 1 (VGluT1) during ribbon synapse maturation (P10) and a reduction in the number of calretinin<sup>+</sup> retinal ganglion cells (RGCs) (adults). …”